LYSINGLUTAMINSÄUREDIPEPTIDDERIVATE

Patent europeic · EP2849882 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2849882
Numer da la dumonda
EP13722408
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-05-2013
Publitgà
25-03-2015
Concedì
14-06-2017
La protecziun finescha il pli tard
12-05-2033
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07C 271/22 (2006.01)
Prioritad
EP 12168119 15.05.2012
Dumonda PCT
PCT/EP2013/059759 13.05.2013
Publicaziun PCT
WO2013/171135 21.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  5. 14-06-2017

    Concedì

    Published in Swissreg on 14.06.2017

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

PUENTENER, Kurt

CH-4052 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.